FDA Needs Rule Change For DMAA Crackdown, Suit Says

By Juan Carlos Rodriguez (November 7, 2013, 2:38 PM EST) -- A weight loss and energy supplement maker hit the U.S. Food and Drug Administration with a lawsuit on Tuesday that accuses it of improperly issuing a detention order on products that contain a controversial stimulant, saying the agency must first go through a formal rule-making process.

Georgia-based Hi-Tech Pharmaceuticals Inc. said in its complaint, filed in D.C. federal court, that the FDA has not engaged in the rule-making process necessary to formally ban the stimulant dimethylamylamine, or DMAA, but still issued an administrative detention order against the company's dietary supplement products that are made with it. Hi-Tech said the FDA has...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Subscribers Only

Nature of Suit

Subscribers Only


Subscribers Only

Date Filed

Subscribers Only

Law Firms


Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!